Key Points
- L1 Capital increased its Anteris Technologies Global position by purchasing 74,286 shares at an average $7.72, a transaction worth approximately $573,488. It subsequently owned 4,877,827 shares valued at about $37.7 million.
- AVR shares opened at $7.61 and were down 2.1%, with the stock trading between a 52-week low of $3.30 and high of $11.06. The company reported a quarterly loss of $0.30 per share, missing estimates, while revenue also fell short of expectations.
- Analyst sentiment remains a “Moderate Buy”, with four Buy ratings and one Sell rating and an average price target of $16.00, despite the company’s negative profitability metrics and recent selling by L1 Capital.
Anteris Technologies Global Corp. (NASDAQ:AVR - Get Free Report) major shareholder L1 Capital Pty Ltd acquired 74,286 shares of the stock in a transaction on Wednesday, September 30th. The stock was bought at an average price of $7.72 per share, for a total transaction of $573,487.92. Following the transaction, the insider owned 4,877,827 shares in the company, valued at approximately $37,656,824.44. This represents a 1.55% increase in their position. The purchase was disclosed in a filing with the SEC, which is available at this hyperlink. Major shareholders that own at least 10% of a company's shares are required to disclose their sales and purchases with the SEC.
L1 Capital Pty Ltd also recently made the following trade(s):
- On Thursday, October 1st, L1 Capital Pty Ltd bought 322,940 shares of Anteris Technologies Global stock. The shares were purchased at an average cost of $7.60 per share, with a total value of $2,454,344.00.
- On Friday, August 28th, L1 Capital Pty Ltd sold 7,800 shares of Anteris Technologies Global stock. The shares were sold at an average price of $8.83, for a total transaction of $68,874.00.
- On Tuesday, August 11th, L1 Capital Pty Ltd sold 375,815 shares of Anteris Technologies Global stock. The shares were sold at an average price of $9.30, for a total transaction of $3,495,079.50.
- On Monday, August 10th, L1 Capital Pty Ltd sold 251,844 shares of Anteris Technologies Global stock. The stock was sold at an average price of $9.10, for a total transaction of $2,291,780.40.
- On Thursday, August 6th, L1 Capital Pty Ltd sold 174,721 shares of Anteris Technologies Global stock. The shares were sold at an average price of $8.10, for a total transaction of $1,415,240.10.
- On Tuesday, August 4th, L1 Capital Pty Ltd sold 480,608 shares of Anteris Technologies Global stock. The shares were sold at an average price of $8.30, for a total transaction of $3,989,046.40.
- On Wednesday, August 5th, L1 Capital Pty Ltd sold 14,581 shares of Anteris Technologies Global stock. The shares were sold at an average price of $8.23, for a total transaction of $120,001.63.
- On Monday, August 3rd, L1 Capital Pty Ltd sold 475,693 shares of Anteris Technologies Global stock. The stock was sold at an average price of $8.10, for a total transaction of $3,853,113.30.
- On Friday, July 31st, L1 Capital Pty Ltd sold 48,711 shares of Anteris Technologies Global stock. The stock was sold at an average price of $8.15, for a total transaction of $396,994.65.
- On Wednesday, July 29th, L1 Capital Pty Ltd sold 155,505 shares of Anteris Technologies Global stock. The stock was sold at an average price of $8.04, for a total transaction of $1,250,260.20.
Anteris Technologies Global Stock Down 2.1%
NASDAQ:AVR opened at $7.61 on Friday. Anteris Technologies Global Corp. has a 52 week low of $3.30 and a 52 week high of $11.06. The stock has a market capitalization of $741.67 million, a PE ratio of -3.90 and a beta of 1.87. The stock's 50-day moving average price is $8.51 and its 200-day moving average price is $7.98.
Anteris Technologies Global (NASDAQ:AVR - Get Free Report) last announced its quarterly earnings results on Tuesday, August 11th. The company reported ($0.30) earnings per share for the quarter, missing the consensus estimate of ($0.21) by ($0.09). The business had revenue of $1.01 million during the quarter, compared to analysts' expectations of $1.50 million. Anteris Technologies Global had a negative net margin of 4,619.27% and a negative return on equity of 77.69%. During the same quarter in the prior year, the firm earned ($0.58) EPS. Sell-side analysts expect that Anteris Technologies Global Corp. will post -1.21 earnings per share for the current fiscal year.
Institutional Inflows and Outflows
Hedge funds have recently modified their holdings of the stock. BlackRock Inc. purchased a new stake in Anteris Technologies Global during the 2nd quarter worth approximately $56,846,000. ADAR1 Capital Management LLC acquired a new stake in shares of Anteris Technologies Global in the second quarter worth approximately $30,979,000. Bank of New York Mellon Corp acquired a new stake in shares of Anteris Technologies Global in the second quarter worth approximately $2,292,000. Perceptive Advisors LLC increased its position in shares of Anteris Technologies Global by 104.4% during the first quarter. Perceptive Advisors LLC now owns 3,425,476 shares of the company's stock worth $19,011,000 after purchasing an additional 1,750,000 shares in the last quarter. Finally, Militia Capital Management LLC purchased a new stake in shares of Anteris Technologies Global during the first quarter worth approximately $3,358,000.
Wall Street Analyst Weigh In
Several research analysts have recently weighed in on the company. Weiss Ratings reaffirmed a "sell (d-)" rating on shares of Anteris Technologies Global in a research note on Wednesday, August 26th. Cantor Fitzgerald reissued an "overweight" rating and issued a $15.00 price target on shares of Anteris Technologies Global in a research note on Friday, August 14th. Four research analysts have rated the stock with a Buy rating and one has given a Sell rating to the company's stock. Based on data from MarketBeat, the company presently has an average rating of "Moderate Buy" and an average target price of $16.00.
Read Our Latest Report on AVR
About Anteris Technologies Global
(
Get Free Report)
Anteris Technologies Global Corp. is a medical device company focused on developing advanced technologies for structural heart disease. Its primary product candidate is the DurAVR transcatheter heart valve, designed to treat aortic valve stenosis through a minimally invasive transcatheter aortic valve replacement procedure.
The DurAVR valve is based on Anteris' ADAPT tissue-engineering technology and is manufactured as a single-piece valve intended to replicate the performance and natural hemodynamics of a healthy human aortic valve.
Featured Stories
This instant news alert was generated by narrative science technology and financial data from InsiderTrades.com in order to provide readers with the fastest and most accurate reporting. Please send any questions or comments about this story to [email protected].
